Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening-Reference-Cited by-同舟云学术

Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening

Published:2021-03-01 Issue:3 Volume:24 Page:177-186
ISSN:1029-2977
Container-title:Archives of Iranian Medicine
language:en
Short-container-title:Arch Iran Med

Author:

Poustchi Hossein¹,Alaei-Shahmiri Fariba²,Aghili Rokhsareh²,Nobarani Sohrab²,Malek Mojtaba³,Khamseh Mohammad E.²

Affiliation:

1. Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

2. Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran

3. Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran

Publisher

Maad Rayan Publishing Company

Subject

General Medicine

Link

http://www.aimjournal.ir/PDF/aim-24-177.pdf

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis;Digestive Diseases and Sciences;2024-03-04

2. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis;Gut;2023-07-25

3. Ultrasound-Based Hepatic Elastography in Non-Alcoholic Fatty Liver Disease: Focus on Patients with Type 2 Diabetes;Biomedicines;2022-09-23

4. Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus;Endocrine;2021-08-05